Acanthosis nigricans: High prevalence and association with diabetes in a Practice-based Research Network Consortium - A Primary Care Multi-Ethnic Network (PRIME Net) study

Journal of the American Board of Family Medicine

Volumn 23, Issue 4, 2010, Pages 476-485

  Kong, Alberta S ^a   Williams, Robert L ^a   Rhyne, Robert ^a   Urias Sandoval, Virginia ^a   Cardinali, Gina ^a   Weller, Nancy F ^b   Skipper, Betty ^a   Volk, Robert ^b   Daniels, Elvan ^c   Parnes, Bennett ^d   McPherson, Laurie ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Acanthosis nigricans; Diabetes; PBRN; Practice based research; Primary health care; Underserved populations

Indexed keywords

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFORMATION PROCESSING; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; EVIDENCE BASED PRACTICE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PROCEDURES; UNITED STATES; YOUNG ADULT;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; AGED; BIOMEDICAL RESEARCH; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTORS; SOUTHWESTERN UNITED STATES; YOUNG ADULT;

EID: 77955295270     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2010.04.090221     Document Type: Article

References (26)

1. Knowler W, Barrett-Connor E, Fowler S, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
2. Drobac S, Brickman W, Smith T, Binns HJ. Evaluation of a type 2 diabetes screening protocol in an urban pediatric clinic. Pediatrics 2004;114:141-8. (Pubitemid 38857578)
3. Hud JA Jr, Cohen JB, Wagner JM, Cruz PD Jr. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 1992;128: 941-4.
4. Kobaissi HA, Weigensberg MJ, Ball GD, Cruz ML, Shaibi GQ, Goran MI. Relation between acanthosis nigricans and insulin sensitivity in overweight Hispanic children at risk for type 2 diabetes. Diabetes Care 2004;27:1412-6.
5. Litonjua P, Pinero-Pilona A, Aviles-Santa L, Raskin P. Prevalence of acanthosis nigricans in newly diagnosed type 2 diabetes. Endocr Pract 2004;10:101-6.
6. Mukhtar Q, Cleverley G, Voorhees RE, McGrath JW. Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J Adolesc Health 2001;28:372-6. (Pubitemid 32381059)
7. Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care 2002;25: 1009-14. (Pubitemid 41110486)
8. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med 1989;87:269-72.
9. Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM. Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk. Am J Public Health 1994;84:1839-42. (Pubitemid 24355657)
10. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care 1999;22:1655-9.
11. Stuart CA, Gilkison CR, Smith MM, Bosma AM, Keenan BS, Nagamani M. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr (Phila) 1998;37:73-9.
12. Kong A, Williams R, Smith M, et al. Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in Southwestern US primary care practices. Ann Fam Med 2007;5:202-8.
13. Brickman W, Binns HJ, Jovanovic B, Kolesky S, Mancini A, Metzger B. Acanthosis nigricans: a common finding in overweight youth. Pediatr Dermatol 2007;24:601-6.
14. University of New Mexico Health Sciences Center. Primary Care Multiethnic Network [homepage]. Available at http://hsc.unm.edu/som/primenet/. Accessed 15 May 2010.
15. Binns HJ, Lanier D, Pace WD, et al. Describing primary care encounters: the Primary Care Network Survey and the National Ambulatory Medical Care Survey. Ann Fam Med 2007;5:39-47.
16. University of New Mexico Health Sciences Center. Appendix 9. Diabetes Health History Survey. Available at http://hsc.unm.edu/som/primenet/documents/ pdf/AN-Health-History-survey.pdf. Accessed 15 May 2010.
17. Williams R, McPherson L, Kong A, Skipper B, Weller N. Internet-based training in a practicebased research network consortium: a report from the Primary Care Multiethnic Network (PRIME Net). J Am Board Fam Med 2009;22:446-52.
18. University of New Mexico Health Sciences Center. PRIME-Net Acanthosis nigricans CME. Available at http://hsc.unm.edu/som/primenet/an-cme.shtml. Accessed 15 May 2010.
19. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005;162:199-200.
20. Copeland K, Pankratz K, Cathey V, et al. Acanthosis nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children. J Okla State Med Assoc 2006;99:19-24.
21. Yamazaki H, Ito S, Yoshida H. Acanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children. Pediatr Int 2003;45:701-5.
22. Bonet B, Viana M, Sanchez-Vera I, Quintanar A, Martinez J, Espino M. Adipose tissue and liver lipid metabolism in obese children: role of the body mass index and the presence of acanthosis nigricans. Diabet Med 2007;24:1190-8.
23. Guran T, Turan S, Akcay T, Bereket A. Significance of acanthosis nigricans in childhood obesity. J Paediatr Child Health 2008;44:338-41.
24. Fareau G, Maldonado M, Oral E, Balasubramanyam A. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome. Metabolism 2006;56:670-5.
25. Romo A, Benavides S. Treatment options in insulin resistance obesity-related acanthosis nigricans. Ann Pharmacother 2008;42:1090-4.
26. Sloane PD, Dolor RJ, Halladay J. Increasing the role of practice networks in medical research. J Am Board Fam Med 2009;22:348-51.